MANGALAM Intraday Analysis...

MANGALAM Share Price

Open 157.50 Change Price %
High 160.00 1 Day -1.90 -1.23
Low 150.30 1 Week 5.10 3.46
Close 152.45 1 Month 5.35 3.64
Volume 75359 1 Year 12.35 8.82
52 Week High 214.90
52 Week Low 123.65
MANGALAM Important Levels
Resistance 2 161.44
Resistance 1 157.74
Pivot 154.25
Support 1 147.16
Support 2 143.46
NSE INDIA Most Active Stocks
HDFCLIFE 344.60 18.83%
RCOM 12.10 3.42%
HDIL 63.95 7.03%
JPASSOCIAT 18.65 -0.27%
RTNPOWER 7.60 5.56%
BANKBARODA 183.55 0.41%
SUZLON 13.70 1.86%
PNB 190.80 0.63%
SBIN 337.50 1.23%
DLF 223.85 7.26%
More..
NSE INDIA Top Gainers Stocks
SUNDARAM 4.20 20.00%
NAGAROIL 3.90 20.00%
PKTEA 229.90 19.99%
PROVOGE 5.75 19.79%
HDFCLIFE 344.60 18.83%
ZUARIGLOB 227.70 14.42%
RENUKA 17.55 13.96%
MAHASTEEL 69.10 13.84%
BALAMINES 613.10 13.60%
PATINTLOG 87.90 12.84%
More..
NSE INDIA Top Losers Stocks
VIPCLOTHNG 54.30 -14.01%
SAMTEL 0.45 -10.00%
LSIL 2.05 -8.89%
WSI 6.40 -7.91%
NBIFIN 2752.40 -6.70%
PRADIP 2.20 -6.38%
MOHITIND 47.55 -6.12%
CUBEXTUB 30.40 -5.00%
PINCON 38.00 -5.00%
STCINDIA 207.20 -5.00%
More..

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

MANGALAM Technical Analysis 1.5
As on 17th Nov 2017 MANGALAM Share Price closed @ 152.45 and we RECOMMEND Sell for LONG-TERM with Stoploss of 156.32 & Buy for SHORT-TERM with Stoploss of 147.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
MANGALAM Target for November
1st Target up-side 159.87
2nd Target up-side 166.36
3rd Target up-side 172.85
1st Target down-side 141.34
2nd Target down-side 134.84
3rd Target down-side 128.35
MANGALAM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 56.60 Sideways
MFI (14) MFI is 55.60 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -50.33 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 145.00
10 Day Avg Volume Traded 31.32 % More then 10 Day Average Volume
MANGALAM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
MANGALAM Address
MANGALAM
N/A
MANGALAM Latest News
Mangalam Drugs And Organics Limited   Moneycontrol.com   - 19th Mar 15
Clarification sought from Mangalam Drugs & Organics Ltd   Hindu Business Line   - 19th Mar 15
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 17th Feb 15
Mangalam Drugs' director Rajendra Prasad Mimani resigns   Moneycontrol.com   - 03rd Feb 15
They lied to me for 15 years of my life, says asbestosis-afflicted labourer   Mid-Day   - 21st Jul 14
Fire stops work at Mangalam Organics plant in Maharastra   Business Standard   - 07th Feb 14
CRISIL ratings for Indian debt instruments-Feb 4   Reuters   - 04th Feb 14
Dujodwala Products changes its name to Mangalam Organics   Moneycontrol.com   - 05th Nov 13
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 09th Apr 12
Indian takeovers abroad   The Economist   - 01st Mar 12
Interactive Technical Analysis Chart Mangalam Drugs And Organics Limited ( MANGALAM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mangalam Drugs And Organics Limited
MANGALAM Business Profile
Mangalam Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5.57 crore.The company has reported a standalone sales of Rs 28.21 crore and a Net Loss of Rs 0.97 crore for the quarter ended Sep 2013.The company management includes Govardhan M Dhoot - Chairman, Subhash C Khattar - Ind. Non-Executive Director, Rajendraprasad Mimani - Ind. Non-Executive Director. It is listed on the BSE with a BSE Code of 532637 and the NSE with an NSE Code of MANGALAM.Its Registered office is at No 292, Princess Street, 2nd Floor, Near Flyover,,Marine Lines Mumbai,Maharashtra - 400002.Their Registrars are Link Intime India Pvt. Ltd.